**Core Concept**
The question is testing the knowledge of aggressive human malignancies, focusing on **acute promyelocytic leukemia (APL)**, a subtype of **acute myeloid leukemia (AML)**. APL is characterized by the accumulation of immature granulocytes, leading to coagulopathy and hemorrhagic complications.

**Why the Correct Answer is Right**
APL is highly malignant and rapidly progressive, with a high risk of bleeding due to **disseminated intravascular coagulation (DIC)**. Delay in treatment can lead to fatal hemorrhages, making prompt intervention crucial. The disease is often associated with a **translocation between chromosomes 15 and 17**, leading to the formation of the **PML-RARA fusion gene**.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because, while other leukemias can be aggressive, they do not typically have the same level of rapid progression and risk of death within days as APL.
**Option B:** Incorrect as it is not specified, but generally, other options like solid tumors or lymphomas do not progress as rapidly as APL.
**Option C:** Incorrect because, similar to option B, it lacks specificity and is not typically associated with the rapid progression seen in APL.
**Option D:** Incorrect for the same reasons as options B and C, lacking the specific characteristics of APL.

**Clinical Pearl / High-Yield Fact**
APL is a medical emergency requiring immediate attention. The disease's rapid progression and high risk of fatal hemorrhages make prompt diagnosis and treatment essential.

**Correct Answer:** D. Acute Promyelocytic Leukemia.